45 results in Exploration of Targeted Anti-tumor Therapy
Latest
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Review
Biliary tract cancers: advances in diagnostic and management
James Gutmans, Hiba Mechahougui
Published: June 23, 2025 Explor Target Antitumor Ther. 2025;6:1002328
This article belongs to the special issue Liquid Biopsy: Has Already Changed the Clinical Decision-Making in Solid Tumors Treatment?
Open Access
Perspective
Future perspectives: targeting fibroblast growth factor receptor 1 to enhance the efficacy of immunotherapy
Ilya Tsimafeyeu
Published: June 20, 2025 Explor Target Antitumor Ther. 2025;6:1002327
Open Access
Review
An overview of the feasibility of nanomedicine in pancreatic cancer theranostics
Kyriakos Kokkinogoulis ... Mersini Makropoulou
Published: June 18, 2025 Explor Target Antitumor Ther. 2025;6:1002326
This article belongs to the special issue Use of Different Radiation Treatment Modalities in Cancer Therapy: The Role of Inflammation and Immune Response
Open Access
Original Article
Comparison of outcomes of neoadjuvant chemotherapy in BRCA1- versus BRCA2-associated breast and ovarian cancers
Anna Sokolenko ... Evgeny Imyanitov
Published: June 18, 2025 Explor Target Antitumor Ther. 2025;6:1002325
Open Access
Review
Osteosarcoma: current insights and advances
Guraustin S. Brar ... Yujiang Fang
Published: June 15, 2025 Explor Target Antitumor Ther. 2025;6:1002324
Open Access
Original Article
Mutational landscape of epidermoid carcinoma of the penis in a Brazilian cohort
Renato Mendes Rossi De Lucca ... Rodolfo Borges dos Reis
Published: June 06, 2025 Explor Target Antitumor Ther. 2025;6:1002323
This article belongs to the special issue Predictive and Prognostic Biomarkers in Cancer: Towards the Precision Medicine Era
Open Access
Review
Role of exosomes in transforming growth factor-β-mediated cancer cell plasticity and drug resistance
Tatiana Ruksha, Nadezhda Palkina
Published: June 05, 2025 Explor Target Antitumor Ther. 2025;6:1002322
Open Access
Review
Circulating tumor cells: overcoming challenges of detecting a needle in a haystack
Zhuldyz Myrkhiyeva ... Aliya Bekmurzayeva
Published: May 29, 2025 Explor Target Antitumor Ther. 2025;6:1002321
This article belongs to the special issue Liquid Biopsy: Has Already Changed the Clinical Decision-Making in Solid Tumors Treatment?
Open Access
Original Article
A viral circular RNA in Kaposi’s sarcoma-associated herpesvirus modulates viral and host gene expression during latent and lytic replication
Soleil Torres ... Rolf Renne
Published: May 29, 2025 Explor Target Antitumor Ther. 2025;6:1002320
This article belongs to the special issue Potential of Non-Coding RNAs in Cancer Research and Treatment
Open Access
Review
The DNA methylation landscape of musculoskeletal sarcomas
Mariana Chantre-Justino, Walter Meohas
Published: May 26, 2025 Explor Target Antitumor Ther. 2025;6:1002319
Open Access
Original Article
Prognostic impact of biomarkers in PMBCL: rationale for early integration of immune checkpoint inhibitors
Yana K. Mangasarova ... Andrey B. Sudarikov
Published: May 20, 2025 Explor Target Antitumor Ther. 2025;6:1002318
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Commentary
The role of circulating tumor DNA (ctDNA) in urothelial cancers
Jeanny B. Aragon-Ching
Published: May 19, 2025 Explor Target Antitumor Ther. 2025;6:1002317
This article belongs to the special issue Liquid Biopsy: Has Already Changed the Clinical Decision-Making in Solid Tumors Treatment?
Open Access
Systematic Review
Utility of CA-125 for diagnosis and prognosis of breast cancer: a systematic review
Zohre Momenimovahed ... Ibrahim Alkatout
Published: May 15, 2025 Explor Target Antitumor Ther. 2025;6:1002316
Open Access
Review
Harnessing the power of tumor-draining lymph nodes: unveiling predictive biomarkers for immune checkpoint inhibitor
Zihan Chen ... Lei Wang
Published: May 13, 2025 Explor Target Antitumor Ther. 2025;6:1002315
This article belongs to the special issue Novel Biomarkers in the Immunotherapy Era
Open Access
Review
The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection
David Sinclair Thomas Junior ... Yong-Jie Lu
Published: May 13, 2025 Explor Target Antitumor Ther. 2025;6:1002314
Open Access
Review
Neoantigen-based immunotherapy: advancing precision medicine in cancer and glioblastoma treatment through discovery and innovation
Moawiah M Naffaa ... Valiko Begiashvili
Published: April 27, 2025 Explor Target Antitumor Ther. 2025;6:1002313
Open Access
Review
Cytokine-based immunotherapy for gastric cancer: targeting inflammation for tumor control
Mathan Muthu Chinakannu Marimuthu ... Hitesh Chopra
Published: April 26, 2025 Explor Target Antitumor Ther. 2025;6:1002312
Open Access
Review
Viral infections and immune modulation in bladder cancer: implications for immunotherapy
Lívia Bitencourt Pascoal ... Leonardo O. Reis
Published: April 24, 2025 Explor Target Antitumor Ther. 2025;6:1002311
This article belongs to the special issue Comprehensive Immunotherapy of Solid Tumors
Open Access
Review
Modulation of anti-tumour immunity by XPO1 inhibitors
Jack G. Fisher ... Matthew D. Blunt
Published: April 23, 2025 Explor Target Antitumor Ther. 2025;6:1002310
This article belongs to the special issue Immune Checkpoint Therapy and Biomarkers in Cancer
Open Access
Case Report
Eosinophil cytolysis with or without ETosis in four cases of human gastric cancer: a comparative ultrastructural study
Rosario Caruso ... Luciana Rigoli
Published: April 21, 2025 Explor Target Antitumor Ther. 2025;6:1002309
